Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis

• James D. Berry ,

  * E-mail: jdberry@partners.org

  Affiliation Neurology Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Jeremy M. Shefner,

  Affiliation Department of NeurologyState University of New York Upstate Medical University, Syracuse, New York, United States of America

  ⨯
• Robin Conwit,

  Affiliation National Institute of Neurologic Disorders and Stroke, Bethesda, Maryland, United States of America

  ⨯
• David Schoenfeld,

  Affiliation Department of Biostatistics, Massachusetts General Hospital, Boston, Massachusetts, United States of America

  ⨯
• Myles Keroack,

  Affiliation Department of Gastroenterology, Marshfield Clinic, Eau Claire, Wisconsin, United States of America

  ⨯
• Donna Felsenstein,

  Affiliation Infectious Disease Unit/Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Lisa Krivickas,

  Affiliation Neurology Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• William S. David,

  Affiliation Neurology Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Francine Vriesendorp,

  Affiliation Department of NeurologyState University of New York Upstate Medical University, Syracuse, New York, United States of America

  ⨯
• Alan Pestronk,

  Affiliation Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, United States of America

  ⨯
• James B. Caress,

  Affiliation Department of Neurology, Wake Forest University, Winston-Salem, North Carolina, United States of America

  ⨯
• Jonathan Katz,

  Affiliation Department of Neurology, California Pacific Medical Center, San Francisco, California, United States of America

  ⨯
• Ericka Simpson,

  Affiliation Department of Neurology, Methodist Neurological Institute, Houston, Texas, United States of America

  ⨯
• Jeffrey Rosenfeld,

  Affiliation Department of Neurology, University of California San Francisco Fresno, Neuroscience Institute, Fresno, California, United States of America

  ⨯
• Robert Pascuzzi,

  Affiliation Department of Neurology, Indiana University, Indianapolis, Indiana, United States of America

  ⨯
• Jonathan Glass,

  Affiliation Department of Neurology, Emory University, Atlanta, Georgia, United States of America

  ⨯
• Kourosh Rezania,

  Affiliation Department of Neurology, University of Chicago, Chicago, Illinois, United States of America

  ⨯
• Jeffrey D. Rothstein,

  Affiliation Department of Neurology, Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• David J. Greenblatt,

  Affiliation Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, Massachusetts, United States of America

  ⨯
• Merit E. Cudkowicz,

  Affiliation Neurology Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
•  [ ... ],
• for the Northeast ALS Consortium

  ¶Members of the Northeast ALS Consortium are provided in File S1

  ⨯
• [ view all ]
• [ view less ]